company background image
0Y6X logo

Medtronic LSE:0Y6X Stock Report

Last Price

US$83.54

Market Cap

US$111.1b

7D

-0.4%

1Y

5.9%

Updated

27 Mar, 2024

Data

Company Financials +

0Y6X Stock Overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.

0Y6X fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Medtronic plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medtronic
Historical stock prices
Current Share PriceUS$83.54
52 Week HighUS$91.91
52 Week LowUS$68.87
Beta0.77
1 Month Change-0.13%
3 Month Change0.98%
1 Year Change5.88%
3 Year Change-29.72%
5 Year Change-6.09%
Change since IPO1.41%

Recent News & Updates

Recent updates

Shareholder Returns

0Y6XGB Medical EquipmentGB Market
7D-0.4%-1.1%2.2%
1Y5.9%2.3%3.7%

Return vs Industry: 0Y6X exceeded the UK Medical Equipment industry which returned 2.3% over the past year.

Return vs Market: 0Y6X exceeded the UK Market which returned 3.7% over the past year.

Price Volatility

Is 0Y6X's price volatile compared to industry and market?
0Y6X volatility
0Y6X Average Weekly Movement1.9%
Medical Equipment Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0Y6X has not had significant price volatility in the past 3 months.

Volatility Over Time: 0Y6X's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194995,000Geoff Marthahttps://www.medtronic.com

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.

Medtronic plc Fundamentals Summary

How do Medtronic's earnings and revenue compare to its market cap?
0Y6X fundamental statistics
Market capUS$111.14b
Earnings (TTM)US$4.20b
Revenue (TTM)US$32.32b

26.5x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0Y6X income statement (TTM)
RevenueUS$32.32b
Cost of RevenueUS$11.08b
Gross ProfitUS$21.24b
Other ExpensesUS$17.04b
EarningsUS$4.20b

Last Reported Earnings

Jan 26, 2024

Next Earnings Date

May 23, 2024

Earnings per share (EPS)3.16
Gross Margin65.72%
Net Profit Margin13.00%
Debt/Equity Ratio48.3%

How did 0Y6X perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

87%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.